← Back to Search

Placebo

Vitamin D (4000 IU) for Vitamin D

N/A

Waitlist Available

Led By Wesley Bonam, BSc, MBBS, FAIMS, MRSH

Research Sponsored by Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one year

Awards & highlights

Study Summary

This trial will test whether vitamin D supplementation can improve immunological outcomes for patients with tuberculosis.

Eligible Conditions

Vitamin D
Immunity
Tuberculosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cell-mediated immunological markers

Immune function

Vitamin D status

Secondary outcome measures

HIV disease progression

TB treatment outcomes

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: Vitamin D (600 IU)Experimental Treatment1 Intervention

Group II: Vitamin D (4000 IU)Experimental Treatment1 Intervention

Group III: Vitamin D (2000 IU)Experimental Treatment1 Intervention

Group IV: PlaceboPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Arogyavaram Medical CentreOTHER

3 Previous Clinical Trials

3,200 Total Patients Enrolled

Cornell UniversityLead Sponsor

166 Previous Clinical Trials

14,089,660 Total Patients Enrolled

Wesley Bonam, BSc, MBBS, FAIMS, MRSHPrincipal InvestigatorArogyavaram Medical Centre (India)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is this research trial open for participation?

"For this trial, 200 individuals between the ages of 18 and 60 who are deficient in vitamin d need to be recruited. To qualify for enrollment, patients must have an active tuberculosis diagnosis as confirmed by GeneXpert testing and additionally provide evidence of HIV infection via enzyme-linked immunosorbent assay (ELISA) results from AMC's HIV clinic medical records."

Answered by AI

Are there currently any open recruitment spots for this experiment?

"According to the information recorded on clinicaltrials.gov, this particular trial is not presently accepting candidates. This study was initially listed on June 1st 2021 and the last update occurred on September 8th 2020. However, there are 181 other medical studies actively recruiting at present time."

Answered by AI